34. Mertens RA, O’Hara PJ, Hertzer NR, et al. Surgical management of infrainguinal arterial prosthetic

graft infections: review of a thirty-five-year experience. J Vasc Surg 1995;21(5):782–791.

35. Marsan BU, Curl R, Pillai L, et al. The thrombosed prosthetic graft is a risk for infection of an

adjacent graft. Am J Surg 1996;172(2):175–177.

36. Brothers TE, Robison JG, Elliott BM. Predictors of prosthetic graft infection after infrainguinal

bypass. J Am Coll Surg 2009;208(4):557–561.

37. Rodrigues dos Santos C, Casaca R, Crespo Mendes de Almeida J, et al. Enteric repair in

aortoduodenal fistulas: a forgotten but often lethal player. Ann Vasc Surg 2014;28(3):756–762.

38. Jonker FH, Heijman R, Trimarchi S, et al. Acute management of aortobronchial and

aortoesophageal fistulas using thoracic endovascular aortic repair. J Vasc Surg 2009;50(5):999–

1004.

39. Antoniou GA, Koutsias S, Antoniou SA, et al. Outcome after endovascular stent graft repair of

aortoenteric fistula: a systematic review. J Vasc Surg 2009;49(3):782–789.

40. Lawlor DK, DeRose G, Harris KA, et al. Primary aorto/iliac-enteric fistula-report of 6 new cases.

Vasc Endovascular Surg 2004;38(3):281–286.

41. Hallett JW Jr, Marshall DM, Petterson TM, et al. Graft-related complications after abdominal aortic

aneurysm repair: reassurance from a 36-year population-based experience. J Vasc Surg

1997;25(2):277–284.

42. Wright DJ, Earnst CB, Evans JR, et al. Ureteral complications and aortoiliac reconstruction. J Vasc

Surg 1990;11(1):29–35.

43. Orton DF, LeVeen RF, Saigh JA, et al. Aortic prosthetic graft infections: radiologic manifestations

and implications for management. Radiographics 2000;20(4):977–993.

44. Low RN, Wall SD, Jeffrey RB Jr, et al. Aortoenteric fistula and perigraft infection: evaluation with

CT. Radiology 1990;175(1):157–162.

45. Macedo TA, Stanson AW, Oderich GS, et al. Infected aortic aneurysms: imaging findings. Radiology

2004;231(1):250–257.

46. Sueyoshi E, Sakamoto I, Kawahara Y, et al. Infected abdominal aortic aneurysm: early CT findings.

Abdom Imaging 1998;23(6):645–648.

47. Modrall JG, Clagett GP. The role of imaging techniques in evaluating possible graft infections.

Semin Vasc Surg 1999;12(4):339–347.

48. O’Hara PJ, Borkowski GP, Hertzer NR, et al. Natural history of periprosthetic air on computerized

axial tomographic examination of the abdomen following abdominal aortic aneurysm repair. J Vasc

Surg 1984;1(3):429–433.

49. Sawhney R, Kerlan RK, Wall SD, et al. Analysis of initial CT findings after endovascular repair of

abdominal aortic aneurysm. Radiology 2001;220(1):157–160.

50. Chung J, Clagett GP. Neoartoiliac system (NAIS) procedure for the treatment of the infected aortic

graft. Sem Vasc Surg 2011;24(4):220–226.

51. Shahidi S, Eskil A, Lundof E, et al. Detection of abdominal aortic graft infection: comparison of

magnetic resonance imaging and indium-labeled white blood cell scanning. Ann Vasc Surg

2007;21(5):586–592.

52. Olofsson PA, Auffermann W, Higgins CB, et al. Diagnosis of prosthetic aortic graft infection by

magnetic resonance imaging. J Vasc Surg 1988;8(2):99–105.

53. Auffermann W, Olofsson PA, Rabahie GN, et al. Incorporation versus infection of retroperitoneal

aortic grafts: MR imaging features. Radiology 1989;172(2):359–362.

54. Fiorani P, Speziale F, Rizzo L, et al. Detection of aortic graft infection with leukocytes labeled with

technetium 99 m-hexametazime. J Vasc Surg 1993;17(1):87–95.

55. Palestro CJ, Torres MA. Radionuclide imaging of nonosseous infection. Q J Nucl Med

1999;43(1):46–60.

56. Ketai L, Hartshorne M. Potential uses of computed tomography-SPECT and computed tomographycoincidence fusion images of the chest. Clin Nucl Med 2001;26(5):433–441.

57. Erba PA, Leo G, Sollini M, et al. Radiolabelled leucocyte scintigraphy versus conventional

radiological imaging for the management of late, low-grade vascular prosthesis infections. Eur J

Nucl Med Mol Imaging 2014;41(2):357–368.

2540

58. Fukuchi K, Ishida Y, Higashi M, et al. Detection of aortic graft infection by fluorodeoxyglucose

positron emission tomography: comparison with computed tomographic findings. J Vasc Surg

2005;42(5):919–925.

59. Spacek M, Belohlavek O, Votrubova J, et al. Diagnostics of “non-acute” vascular prosthesis

infection using 18 F-FDG PET/CT: our experience with 96 prostheses. Eur J Nucl Med Mol Imaging

2009;36(5):850–858.

60. Bruggink JL, Glaudemans AW, Saleem BR, et al. Accuracy of FDG-PET-CT in the diagnostic work-up

of vascular prosthetic graft infection. Eur J Vasc Endovasc Surg 2010;40(3):348–354.

61. Basu S, Chryssikos T, Moghadam-Kia S, et al. Positron emission tomography as a diagnostic tool in

infection: present role and future possibilities. Semin Nucl Med 2009;39(1):36–51.

62. Lan XL, Zhang YX, Wu ZJ, et al. The value of dual time point (18)F-FDG PET imaging for the

differentiation between malignant and benign lesions. Clin Radiol 2008;63(7):756–764.

63. Boellard R, O’Doherty MJ, Weber WA, et al. FDG PET and PET/CT: EANM procedure guidelines for

tumour PET imaging version 1.0. Eur J Nucl Med Mol Imaging 2010;37(1):181–200.

64. Thompson WM, Jackson DC, Johnsrude IS. Aortoenteric and paraprosthetic-enteric fistulas:

radiologic findings. AJR 1976;127:235–242.

65. Katz BH, Black RA, Colley DP. CT-guided fine needle aspiration of a periaortic collection. J Vasc

Surg 1987;5(5):762–764.

66. Golder W, Wolf KJ. CT-guided aspiration biopsy of infected aortic graft in a patient with

hypertrophic osteoarthropathy: saline injection to improve diagnostic yield-a case report. Acta

Radiol 2001;42(1):59–62.

67. Hsu RB, Chang CI, Wu IH, et al. Selective medical treatment of infected aneurysms of the aorta in

high risk patients. J Vasc Surg 2009;49(1):66–70.

68. Calligaro KD, Veith FJ, Schwartz ML, et al. Selective preservation of infected prosthetic arterial

grafts. analysis of a 20-year experience with 120 extracavitary-infected grafts. Ann Surg

1994;220(4):461–471.

69. Dosluoglu HH, Loghmanee C, Lall P, et al. Management of early (<30 day) vascular groin

infections using vacuum-assisted closure alone without muscle flap coverage in a consecutive

patient series. J Vasc Surg 2010;51(5):1160–1166.

70. Berger P, de Bie D, Moll FL, et al. Negative pressure wound therapy on exposed prosthetic vascular

grafts in the groin. J Vasc Surg 2012;56(3):714–720.

71. Calligaro KD, Veith FJ, Yuan JG, et al. Intra-abdominal aortic graft infection: complete or partial

graft preservation in patients at very high risk. J Vasc Surg 2003;38(6):1199–1205.

72. Marone EM, Mascia D, Kahlberg A, et al. Emergent endovascular treatment of a bleeding recurrent

aortoenteric fistula as a “bridge” to definitive surgical repair. J Vasc Surg 2012;55(4):1160–1163.

73. Leonhardt H, Mellander S, Snygg J, et al. Endovascular management of acute bleeding

arterioenteric fistulas. Cardiovasc Intervent Radiol 2008;31(3):542–549.

74. O’Hara PJ, Hertzer NR, Beven BG, et al. Surgical management of infected abdominal grafts: review

of a 25-year experience. J Vasc Surg 1986;3(5):725–731.

75. Reilly LM, Stoney RJ, Goldstone J, et al. Improved management of aortic graft infection: the

influence of operation sequence and staging. J Vasc Surg 1987;5(3):421–431.

76. Seeger JM, Pretus HA, Welborn MB, et al. Long-term outcome after treatment of aortic graft

infection with staged extra-anatomic bypass grafting and aortic graft removal. J Vasc Surg

2000;32(3):451–459.

77. Yeager RA, Taylor LM Jr, Moneta GL, et al. Improved results with conventional management of

infrarenal aortic infection. J Vasc Surg 1999;30(1):76–83.

78. Bandyk DF, Novotney ML, Back MR, et al. Expanded application of in situ replacement for

prosthetic graft infection. J Vasc Surg 2001;34(3):411–420.

79. Armstrong PA, Back MR, Wilson JS, et al. Improved outcomes in the recent management of

secondary aortoenteric fistula. J Vasc Surg 2005;42(4):660–666.

80. Oderich GS, Bower TC, Hofer J, et al. In situ rifampin-soaked grafts with omental coverage and

antibiotic suppression are durable with low reinfection rates in patients with aortic graft enteric

erosion or fistula. J Vasc Surg 2011;53(1):99–107.

81. Oderich GS, Bower TC, Cherry KJ Jr, et al. Evolution from axillofemoral to in situ prosthetic

2541

reconstruction for the treatment of aortic graft infections at a single center. J Vasc Surg

2006;43(6):1166–1174.

82. Batt M, Jean-Baptiste E, O’Conner S, et al. Early and late results of contemporary management of

37 secondary aorto-enteric fistulae. Eur J Vasc Endovasc Surg 2011;41(6):748–757.

83. Harlander-Locke MP, Harmon LK, Lawrence PF, et al. The use of cryopreserved aortoiliac allograft

for aortic reconstruction in the United States. J Vasc Surg 2014;59(3):669–674.

84. Valentine RJ, Timaran CH, Modrall JG, et al. Secondary aortoenteric fistulas versus paraprosthetic

erosions: is bleeding associated with worse outcome? J Am Coll Surg 2008;207(6):922–927.

85. Belair M, Soulez G, Oliva VL, et al. Aortic graft infection: the value of percutaneous drainage. AJR

Am J Roentgenol 1998;171(1):119–124.

86. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative

cardiovascular evaluation and care for noncardiac surgery: a report of the American College of

Cardiology/American Heart Association Task Force on Practice guidelines (writing committee to

revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery.

Circulation 2007;116(17):e418-e500.

87. Lee CH, Hsieh HC, Ko PJ, et al. In situ versus extra-anatomic reconstruction for primary infected

infrarenal abdominal aortic aneurysms. J Vasc Surg 2011;54(1):64–70.

88. Carrel A. Ultimate result of aortic transplantation. J Exp Med 1912;15:389–398.

89. Zwischenberger JB, Shalaby TZ, Conti VR. Viable cryopreserved aortic homograft for aortic valve

endocarditis and annular abscesses. Ann Thorac Surg 1989;48(3):365–370.

90. Kieffer E, Bahnini A, Koskas F, et al. In situ allograft replacement of infected infrarenal aortic

prosthetic grafts: results in forty-three patients. J Vasc Surg 1993;17(2):349–356.

91. Brown KE, Heyer K, Rodriguez H, et al. Arterial reconstruction with cryopreserved human

allografts in the setting of infection: a single-center experience with midterm follow-up. J Vasc Surg

2009;49(3):660–666.

92. Vogt PR, Brunner-LaRocca HP, Lachat M, et al. Technical details with the use of cryopreserved

arterial allografts for aortic infection: influence on early and midterm mortality. J Vasc Surg

2002;35(1):80–86.

93. Verhelst R, LaCroix V, Vraux H, et al. Use of cryopreserved arterial homografts for management of

infected prosthetic grafts: a multi-centric study. Ann Vasc Surg 2000;14(6):602–607.

94. Leseche G, Castier Y, Petit MD, et al. Long-term results of cryopreserved arterial allograft

reconstruction in infected prosthetic grafts and mycotic aneurysms of the abdominal aorta. J Vasc

Surg 2001;34(4):616–622.

95. Villain-Guillot P, Gualtieri M, Bastide L, et al. In vitro activities of different inhibitors of bacterial

transcription against staphylococcus epidermidis biofilm. Antimicrob Agents Chemother

2007;51(9):3117–3121.

96. Bandyk DF, Novotney ML, Back MR, et al. Use of rifampin-soaked gelatin-sealed polyester grafts

for in situ treatment of primary aortic and vascular prosthetic infections. J Surg Res 2001;95(1):44–

49.

97. Mei L, Lu Z, Zhang X, et al. Polymer-Ag nanocomposites with enhanced antimicrobial activity

against bacterial infection. ACS Appl Mater Interfaces 2014;6(18):15813–1521.

98. Koshiko S, Sasajima T, Muraki S, et al. Limitations in the use of rifampicin-gelatin grafts against

virulent organisms. J Vasc Surg 2002;35(4):779–785.

99. Batt M, Jean-Baptiste E, O’Connor S, et al. In-site revascularisation for patients with aortic graft

infection: a single centre experience with silver coated polyester grafts. Eur J Vasc Endovasc Surg

2008;36(2):182–188.

100. Batt M, Magne JL, Alric P, et al. In situ revascularization with silver-coated polyester grafts to treat

aortic infection: early and midterm results. J Vasc Surg 2003;38(5):983–989.

101. Clagett GP, Bowers BL, Lopez-Viego MA, et al. Creation of a neo-aortoiliac system from lower

extremity deep and superficial veins. Ann Surg 1993;218(3):239–248; discussion 248–249.

102. Daenens K, Fourneau I, Nevelsteen A. Ten-year experience in autogenous reconstruction with the

femoral vein in the treatment of aortofemoral prosthetic infection. Eur J Vasc Endovasc Surg

2003;25(3):240–245.

103. Valentine RJ and Clagett GP. Aortic graft infections: replacement with autogenous vein. Cardiovasc

2542

Surg 2001;9(5):419–425.

104. Modrall JG, Sadjadi J, Ali AT, et al. Deep vein harvest: predicting need for fasciotomy. J Vasc Surg

2004;39(2):387–394.

105. Modrall JG, Hocking JA, Timaran CH, et al. Late incidence of chronic venous insufficiency after

deep vein harvest. J Vasc Surg 2007;46(3):520–525; discussion 525.

106. O’Connor S, Andrew P, Batt M, et al. A systematic review and meta-analysis of treatments for

aortic graft infection. J Vasc Surg 2006;44(1):38–45.

107. Edwards WH Jr, Martin RS 3rd, Jenkins JM, et al. Primary graft infections. J Vasc Surg

1987;6(3):235–239.

108. Chang CK, Scali ST, Feezor RJ, et al. Defining utility and predicting outcome of cadaveric lower

extremity bypass grafts in patients with critical limb ischemia. J Vasc Surg 2014;60(6):1554–1564.

109. Biancari F, D’Andrea V, Di Marco C, et al. Meta-analysis of randomized trials on the efficacy of

vascular closure devices after diagnostic angiography and angioplasty. Am Heart J

2010;159(4):518–531.

110. Schneider JR, Oskin SI, Verta MJ Jr. Superficial femoral vein graft interposition in situ repair for

femoral mycotic aneurysm. Ann Vasc Surg 2009;23(1):147–149.

111. Patel A, Taylor SM, Langan EM III, et al. Obdurator bypass: a classic approach for the treatment of

contemporary groin infection. Am Surg 2002;68(8):653–658.

112. Arora S, Weber MA, Fox CJ, et al. Common femoral artery ligation and local debridement: a safe

treatment for infected femoral artery pseudoaneurysms. J Vasc Surg 2001;33(5):990–993.

113. Reddy DJ, Smith RF, Elliott JP Jr, et al. Infected femoral artery false aneurysms in drug addicts:

evolution of selective vascular reconstruction. J Vasc Surg 1986;3(5):718–724.

114. Cheng SW, Fok M, Wong J. Infected femoral pseudoaneurysm in intravenous drug abusers. Br J

Surg 1992;79:510–512.

115. Mousavi SR, Saberi A, Tadayon N, et al. Femoral artery ligation as treatment for infected pseudoaneurysms, secondary to drug injection. Acta Chir Belg 2010;110(2):200–202.

116. Padberg F Jr, Hobson R, Lee B, et al. Femoral pseudoaneurysm from drugs of abuse: ligation or

reconstruction?J Vasc Surg 1992;15(4):642–648.

117. Sorial E, Valentino J, Given CA, et al. The emergency use of endografts in the carotid bifurcation to

control hemorrhage in potentially contaminated fields. J Vasc Surg 2007;46(4):792–798.

118. Lorelli DR, Cambria RA, Seabrook GR, et al. Diagnosis and management of aneurysms involving

the superior mesenteric artery and its branches-a report of four cases. Vasc Endovasc Surg

2003;37(1):59–66.

119. Serafin G, Vroegindeweij D, Boks S, et al. Mycotic aneurysm of the celiac trunk: from early CT sign

to rupture. Cardiovasc Interv Radiol 2005;28(5):677–680.

120. Lai KM, Rosenthal D, Wellons ED, et al. Mycotic superior mesenteric aneurysm. J Vasc Surg

2007;45(1):191.

121. Georges RN, Lipman S, Silvestri F, et al. Endovascular treatment of mycotic hepatic artery

aneurysm in the hostile abdomen-a case report. J Vasc Surg 2001;35(6):477–481.

122. Tierney AB, Palmer FJ. Mycotic aneurysm of the right hepatic artery presenting with obstructive

jaundice. Australas Radiol 1987;31(1):50–52.

123. Ramirez M, Serran C, Castro C, et al. Comparative study of disc diffusion and microdilution

methods in susceptibility testing of micafungin against Candida species. J Antimicrob Chemother

2006;58(4):861–863.

124. Stewart AH, Eyers PS, Earnshaw JJ. Prevention of infection in peripheral arterial reconstruction: a

systematic review and meta-analysis. J Vasc Surg 2007;46(1):148–155.

2543